Lupus Research Alliance and Clinical Affiliate Lupus Therapeutics Form New Collaboration with AstraZeneca to Advance Drug Development in Lupus

The collaboration brings together research expertise, a clinical trial network, and patient engagement

The Lupus Research Alliance (LRA) and clinical affiliate Lupus Therapeutics (LT) which oversees the Lupus Clinical Investigators Network (LuCIN) are pleased to announce a strategic collaboration with AstraZeneca, a leading global biopharmaceutical company, to advance patient-centered research that supports patient engagement, clinical trial participation, and recruitment across AstraZeneca’s development programs in lupus. 

Read full press release

Other News